我国中药出口现状和对策_英文_虞钟.pdf

YU Zhong, et al:Current Status and Development Strategies of TCMM Exportation in China 67 nology of TCMM extra tion is also not so advan ed;it is It is important to strengthen the ommuni ation and diffi ult to ontrol the quality of TCMM preparations; ooperation among governments, trade and a ademi orga- there is a large gap between the GMP of China and that of nizations, to gradually eliminate ultural barriers by pub- developed ountries;quality ontrol of TCMM mostly re- li izing and explaining the theory and ulture of TCM. lies on qualitative analysis and quantitative testing of a Firstly, Chinese must translate the lassi al literature of single omponent;and the data of pharma ologi al test, TCM, unify the on epts and terms, and publish TCM drug effi a y and toxi ologi al test have not been re og- monographs, magazines, and newspapers to oversea oun- nized by international ountries, be ause of the limited tries.Se ondly, they need to ooperate with foreign re- experien e of GCP and GLP implementation in China. sear h institutions in areas su h as pharma odynami nformation barriers me hanisms, quality ontrol, lini al trials and new pro- Information asymmetry is also an export barrier.As du t development.Thirdly, they should establish a quali- the exporter, China holds more information about produ ts fi ation authenti ation system for herbalist do tors and supply, but the importers hold more information on throughout the world.Fourthly, TCM hospitals ought to market demands, i.e.both sides have market information be set up in other ountries. asymmetry.A typi al example is the ase of Longdanxie- Standardization of TCMM ganwan (Pill of Gentiana for Purging Liver-Fir